Search

ENPNewswire-February 10, 2025--Annovis to Present at Oppenheimer's 35th Annual Healthcare Life Sciences Conference (C)2025 ENPublishing - http://www.enpublishing.co.uk Release date- 07022025 - MALVERN - Annovis Bio Inc. (NYSE: ANVS) ('Annovis' or [...]

ENPNewswire-February 6, 2025--Annovis Announces First Patients Entered into Pivotal Phase 3 Study of Buntanetap for Early Alzheimer's Disease (C)2025 ENPublishing - http://www.enpublishing.co.uk Release date- 05022025 - MALVERN - Annovis Bio [...]

ENPNewswire-January 15, 2025--Annovis Granted U.S. Patent for Treatment and Prevention of Acute Brain or Nerve Injuries Securing Global Protection (C)2025 ENPublishing - http://www.enpublishing.co.uk Release date- 14012025 - MALVERN - Annovis [...]

ENPNewswire-January 8, 2025--Annovis Bio Inc. - FDA Accepts Final Protocol for Pivotal Phase 3 Alzheimer's Disease Study, Streamlining Development Pathway (C)2025 ENPublishing - http://www.enpublishing.co.uk Release date- 07012025 - MALVERN - [...]

ENPNewswire-November 26, 2024--Annovis to Host Year-End Investor Webcast on December 11, 2024 (C)2024 ENPublishing - http://www.enpublishing.co.uk Release date- 25112024 - MALVERN - Annovis Bio, Inc. (NYSE: ANVS), a clinical-stage drug [...]

ENPNewswire-November 12, 2024--Annovis Bio Reports Third Quarter Financial Results and Provides Business Update (C)2024 ENPublishing - http://www.enpublishing.co.uk Release date- 11112024 - MALVERN - Annovis Bio, Inc. (NYSE: ANVS) ('Annovis' or [...]

ENPNewswire-October 23, 2024--Annovis to Highlight Buntanetap's Alzheimer's Research Progress with Presentations at CTAD 2024 (C)2024 ENPublishing - http://www.enpublishing.co.uk Release date- 22102024 - MALVERN - Annovis Bio Inc. (NYSE: ANVS) ('Annovis' [...]

ENPNewswire-October 16, 2024--FDA Clears Annovis to Launch Pivotal Phase 3 Alzheimer's Studies, Paving the Way to NDAs (C)2024 ENPublishing - http://www.enpublishing.co.uk Release date- 15102024 - MALVERN - Annovis Bio Inc. [...]

ENPNewswire-October 1, 2024--Annovis Files Three New Patents for Combination Therapies Involving Buntanetap, Trulicity, and Viagra (C)2024 ENPublishing - http://www.enpublishing.co.uk Release date- 30092024 - MALVERN - Annovis Bio Inc. (NYSE: ANVS) [...]

ENPNewswire-August 16, 2024--Annovis Bio Reports Second Quarter Financial Results and Provides Business Update (C)2024 ENPublishing - http://www.enpublishing.co.uk Release date- 15082024 - MALVERN - Annovis Bio Inc. (NYSE: ANVS) ('Annovis' or [...]

ENPNewswire-July 25, 2024--ANNOVIS BIO SECURES U.S. PATENT FOR TREATMENT OF ACUTE TRAUMATIC BRAIN INJURY WITH BUNTANETAP (C)2024 ENPublishing - http://www.enpublishing.co.uk Release date- 24072024 - MALVERN - Annovis Bio Inc. (NYSE: [...]

ENPNewswire-June 28, 2024--ANNOVIS BIO FILES PROVISIONAL PATENT FOR NEW MANUFACTURING PROCESS OF CRYSTALLINE FORM OF BUNTANETAP (C)2024 ENPublishing - http://www.enpublishing.co.uk Release date- 27062024 - MALVERN - Annovis Bio Inc. (NYSE: [...]

ENPNewswire-June 27, 2024--ANNOVIS BIO FILES PATENT FOR NEW COMPOSITION OF MATTER FOR BUNTANETAP (C)2024 ENPublishing - http://www.enpublishing.co.uk Release date- 26062024 - MALVERN - Annovis Bio Inc. (NYSE: ANVS) ('Annovis' or [...]

ENPNewswire-June 6, 2024--ANNOVIS BIO INC. SCHEDULES INVESTOR WEBCAST (C)2024 ENPublishing - http://www.enpublishing.co.uk Release date- 05062024 - MALVERN - Annovis Bio Inc. (NYSE: ANVS) ('Annovis' or the 'Company'), a late-stage clinical [...]

ENPNewswire-May 16, 2024--PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101 (C)2024 ENPublishing - http://www.enpublishing.co.uk Release date- 15052024 - TARRYTOWN - PaxMedica,Inc. (the 'Company' or [...]

ENPNewswire-October 11, 2023--PaxMedica Announces Gold Sponsorship of The BRAIN Foundation's Synchrony Symposia 2023 (C)2023 ENPublishing - http://www.enpublishing.co.uk Release date- 10102023 - TARRYTOWN - PaxMedica, Inc. (Nasdaq: PXMD), a clinical stage [...]

ENPNewswire-January 4, 2023--Vision Energy Submits Environmental Permit Application (C)2023 ENPublishing - http://www.enpublishing.co.uk Release date- 03012023 - JERSEY CITY, N.J. - Vision Energy Corporation (OTCQB:VENG) ('Vision Energy' or the 'Company') is [...]

ENPNewswire-August 20, 2020--University of Kent: From strength to strength for Kent Barbell's President Molly Walsh (C)2020 ENPublishing - http://www.enpublishing.co.uk Release date- 19082020 - Molly Walsh, a student of Sports and [...]